1. Antibody Engineering & Therapeutics
2. Inhalation & Respiratory Drug Delivery
3. Pharmacovigilance & Drug Safety
4. Pre-filled Syringes & Injectables
5. Gut-Brain Axis
6. Probiotics, Human & Skin Microbiome
7. Aseptic Processing Technology
8. CDx/Biomarkers & Biobanking

Antibody Engineering & Therapeutics Agenda

Agenda is being produced and will be announced soon.
Click here to speak at this event
Click here to find the Confirmed speakers
C0005.00_00_55_15.Still053

Day 1

Day 2

Day 1 | 08:00 - 08:20

IRDD Registration & Welcome Coffee

Day 2 | 08:00 - 08:20

Registration and Coffee

Day 1 | 08:20 - 08:30

Chairman's Opening Address

Day 2 | 08:20 - 08:30

Chairman's Opening Address

Part I: The challenges of developing inhalation drugs

Part V: New Approaches to Treating Respiratory Diseases

Day 1 | 08:30 - 09:00

Science base and challenges of therapeutic equivalence of respiratory products.
Jörg Schiewe, Head of Global CMC Experts at Boehringer Ingelheim Pharma GmbH & Co. KG

Day 2 | 08:30 - 09:00

Topic to announce

Masahiro Sakagami, Professor of Pharmaceutics at Virginia Commonwealth University School of Pharmacy

Day 1 | 09:00 - 09:30

IRDD Speed Networking
An innovative approach to maximize networking capabilities through two minute periods, where delegates can meet their peers and exchange business cards before rotating to the next company representative.

Day 2 | 09:00 - 09:30

Shared Decision Making to Improve Adherence in Severe Asthma

Tonya Winders, President and Chief Executive Officer at Allergy & Asthma Network

Day 1 | 09:30 - 10:00

The biological barriers to consider for the development of inhaled biotherapeutics
Nathalie Heuzé-Vourc'h, Research Professor at INSERM, Research Centre for Respiratory Diseases

Day 2 | 09:30 - 10:00

Inhalation therapy for pulmonary arterial hypertension, a pulmonary vascular disease
Fakhrul Ahsan, University Distinguished Professor in the Department of Pharmaceutical Sciences at the TTUHSC

Day 1 | 10:00 - 10:30

Early Phase Clinical Trials for Inhaled Drugs - Challenges and Opportunities
Aernout van Haarst, PhD Director, Scientific Affairs at Celerion

Day 2 | 10:00 - 10:30

Optimising surrogate outcome measures for respiratory trials
Peter Robbins Professor of Physiology at the University of Oxford
10:30 - 11:00

Morning Coffee & Networking Break

Part VI: New analytical insights into dry powder formulations for inhalation

Day 1 | 11:00 - 11:30
Accurate dosimetry predictions for evolving liquid aerosol delivery
Arkadiusz Kuczaj, PhD, Manager Aerosol Research and Dosimetry at Philip Morris International Research and Development
Day 2 | 11:00 - 11:30
Topic to announce

Wayland Rushing, Director, Scientific Affairs at Eurofins BioPharma Product Testing

Part II: Inhalation Formulation Solutions & Technology

Day 1 | 11:30 - 12:00
Formulation and Spray Drying Process Development of Inhaled Biopharmaceuticals
Diana Fernandes, Inhaled Biopharmaceutical Development Scientist at Hovione
Day 2 | 11:30 - 12:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 1 | 12:00 - 12:30
Administration of high dose antibiotic DPI: formulation/device combination for a cystic fibrosis patient-centric product
Francesca Buttini, Associate Professor at University of Parma, Italy
Day 2 | 12:00 - 13:00
Panel Discussion
Future directions in inhalation and respiratory drug delivery research
Day 1 | 12:30 - 13:00
Musings on High Dose Powder Delivery
Jeffry Weers, Ph.D. Chief Technical Officer at Respira Therapeutics, Inc.
13:00 - 14:00

Lunch Break

Day 1 | 14:00 - 14:30
Increasing the drug load in capsule based DPI drug delivery systems
Prof. Dr. Sven Stegemann, Professor of patient centric drug design and manufacturing at the Graz University of Technology, Austria
Day 2 | 14:00 - 14:30
TOP-5 Poster Presentations (5min. On Stage)
Click here to submit your Poster

Part V: New Approaches to Inhalation Product Development and Production

Day 1 | 14:30 - 15:00
Formulation Development Challenges and Pitfalls When Developing Dry Powder Inhalers
Martin Wing-King, Director of Project Management at Quotient Sciences
Day 2 | 14:30 - 15:00
Topic to be announced (Development and commercialization of inhaled therapeutic products)
Michael Castagna, Chief Executive Officer at MannKind Corporation
15:00 - 15:30

Afternoon Coffee & Networking Break

Part IV: Regulatory pathways for inhaled therapies

Day 1 | 15:30 - 16:00
Paving the way towards respiratory medicine using Functional Respiratory Imaging and AI.
Jan De Backer, PhD, CEO at FLUIDDA
Day 2 | 15:30 - 16:00
Development of an Integrated Digital Health Product (DigihalerTM)
Mark Milton-Edwards Head of Product & Health Solutions - Digital Health at Teva Pharmaceuticals
Day 1 | 16:00 - 16:30
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 16:00 - 16:30
Use of 3d printing, Computational fluid dynamics and customised engineering in inhalation pre-clinical development
Simon Moore, Global Lead of Inhalation Science and Engineering at Covance
Day 1 | 16:30 - 17:00
Get it right first time: Inhaler technology and manufacturing
Marco Laackmann, Director Inhalation Technology at Harro Höfliger
Day 2 | 16:30
Chairman's closing remarks & End of the IRDD Event

Part III: Regulatory pathways for inhaled therapies

Day 1 | 17:00 - 17:30
Using a New Human Realistic Approach to In Vitro Characterization to Better Predict In Vivo Performance of Inhaled Aerosols
Dino Farina, Founder and CEO at Proveris Scientific
Day 1 | 17:30 - 18:00
Panel Discussion
Asthma inhalers: what next for the drug delivery tech?

DAY 1 | 20:00 - 22:30

Monday night business dinner

The BioTech Pharma Summit 2021: Gala Dinner

Sponsor this event - Click here
IRDD_Gala_Dinner_New_York_Inhalation_Drug_Delivery

Pharmacovigilance & Drug Safety Agenda

Agenda is being produced and will be announced soon.
Click here to speak at this event
Click here to find the Confirmed speakers
C0019.00_02_41_07.Still126

Pre-filled Syringes & Injectables Agenda

Agenda is being produced and will be announced soon.
Click here to speak at this event
Click here to find the Confirmed speakers
C0245.00_06_51_18.Quadro020

Day 1

Day 2

Day 1 | 08:00 - 08:20

Registration & Welcome Coffee

Day 2 | 08:00 - 08:20

Registration and Coffee

Day 1 | 08:20 - 08:30

Gut-Brain Axis Chairman's Opening Address

Day 2 | 08:20 - 08:30

Gut-Brain Axis Chairman's Opening Address

Day 1 | 08:30 - 09:00

Gut brain axis and neurological diseases
Pierre Lestage, Chief Executive Officer at NeribiOm

Day 2 | 08:30 - 09:00

Harnessing the Potential of Microbiota-related Therapies for Brain Health
Jane A. Foster, Associate Professor at McMaster University

Day 1 | 09:00 - 09:30

Gut-Brain Axis Speed Networking
An innovative approach to maximize networking capabilities through two minute periods, where delegates can meet their peers and exchange business cards before rotating to the next company representative.

Day 2 | 09:00 - 09:30

Deciphering the Gut-Microbiome-Brain Axis Relationship with Metabolomics
Rohan F. Hastie, Ph.D. President & Chief Executive Officer at Metabolon

Day 1 | 09:30 - 10:00

Speaking Sponsorship Available - Have your talk here
Click here to register

Day 2 | 09:30 - 10:00

Intestinal microbiome medicinal product (IMMP): establishing a licensed platform to create novel products
Christian Roghi, Director of Strategic Alliances at CosmosID

Day 1 | 10:00 - 10:30

Do plant-derived exosomes regulate the gut microbiome?
Jennifer K. Spinler, Instructor at Texas Children’s Microbiome Center & Baylor College of Medicine

Day 2 | 10:00 - 10:30

To be announced
Martha Carlin, Chief Executive Officer at The BioCollective
10:30 - 11:00

Morning Coffee & Networking Break

Day 1 | 11:00 - 11:30
Topic to be announced
Rochellys Diaz Heijtz, Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet
Day 2 | 11:00 - 11:30
Microbiome Mediated Appetite Regulation - First Experiences with EnteroSatys
Dr. Sergueï O. Fetissov Professor of physiology at Rouen University and co-founder of TargEDys.
Day 1 | 11:30 - 12:00
Targeting the brain-gut-microbiome axis by ImmuneBioticsTM, a new therapeutic avenue for management of multiple sclerosis
Shahram Lavasani, Founder and CEO at ImmuneBiotech AB
Day 2 | 11:30 - 12:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 1 | 12:00 - 12:30
The gut microbiome as a therapeutic venue for inflammatory diseases of the central nervous system (CNS)
Javier Ochoa-Repáraz, Assistant Professor at Eastern Washington University
Day 2 | 12:00 - 13:00
Panel Discussion
Gut microbiota and its implications for psychiatry: Conclusions and Future Directions for Research
Day 1 | 12:30 - 13:00
Novel Microbiome Approach For Management of Alzheimer Diseases
Satya Prakash, Professor of Biomedical Engineering, Artificial Cells and Organs, Physiology, Experimental Medicine and Surgury in the Faculty of Medicine at McGill University
13:00 - 14:00

Lunch Break

Day 1 | 14:00 - 14:30
Investigating host-microbe interactions and mechanisms of the gut-brain axis in vitro
Eva Maier, Postdoctoral Scientist at AgResearch, Palmerston North, New Zealand
Day 2 | 14:00 - 14:30
TOP-5 Poster Presentations (5min. On Stage)
Click here to submit your poster
Day 1 | 14:30 - 15:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 14:30 - 15:00
Diet & the Gut-Brain Axis: from concept to product
Marcus Böhme, R&D Specialist at Nestlé Research
15:00 - 15:30

Afternoon Coffee & Networking Break

Day 1 | 15:30 - 16:00
The gut-brain and brain-gut axes in human disease
Wouter de Jonge Professor of Neurogastroenterology at AMC, CoFounder of Gut Research
Day 2 | 15:30 - 16:00
From Nutrition to Therapy: Commercialising the Therapeutic Potential of The Microbiome in the Field of Metabolic Diseases
Georges Rawadi CEO at LNC Therapeutics
Day 1 | 16:00 - 16:30
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 16:00 - 16:30
Systemic barrier damage and biomarkers connected to inflammation and the potential role in dysbiosis
Domingo Barber Director Institute for Applied Molecular Medicine at Universidad San Pablo Madrid
Day 1 | 16:30 - 17:00
Panel Discussion
Clinical Trials in the Gut-Brain Axis: Challenges & Opportunities
Day 2 | 16:30
Chairman's closing remarks & End of the Gut-Brain Axis

DAY 1 | 20:00 - 22:30

Monday night business dinner

The BioTech Pharma Summit 2021: Gala Dinner

Sponsor this event - Click here
IRDD_Gala_Dinner_New_York_Inhalation_Drug_Delivery

Day 1

Day 2

Day 1 | 08:00 - 08:20

Probiotics, Human & Skin Microbiome Registration & Welcome Coffee

Day 2 | 08:00 - 08:20

Registration for the 2nd day

Day 1 | 08:20 - 08:30

Chairman's Opening Address

Day 2 | 08:20 - 08:30

Opening of the 2nd day of the Probiotics, Human & Skin Microbiome event

Day 1 | 08:30 - 09:00

Skin Care and microbes
Per Falholt, Director at Novo Nordisk Foundation

Day 2 | 08:30 - 09:00

Considering the Microbiome Interorgans Axis (MIA) as a future option in Health & Diseases
Lionel Breton, Scientific Director, Advanced Research at L’Oreal

Day 1 | 09:00 - 09:30

Probiotics, Human & Skin Microbiome Speed Networking
An innovative approach to maximize networking capabilities through two minute periods, where delegates can meet their peers and exchange business cards before rotating to the next company representative.

Day 2 | 09:00 - 09:30

S-Biomedic approach of direct skin microbiome modulation
Veronika Oudova, Co-founder and Chief Executive Officer at S-Biomedic

Day 1 | 09:30 - 10:00

Speaking Sponsorship Available - Have your talk here
Click here to register

Day 2 | 09:30 - 10:00

Speaking Sponsorship Available - Have your talk here
Click here to register

Day 1 | 10:00 - 10:30

Pre-pro-postbiotics and role in modulating our microbiome – status & case studies
Radhika Bongoni, Business Developer at BaseClear B.V.

Day 2 | 10:00 - 10:30

Feeding your brain & skin: will European Regulation let psychobiotics & skinbiotics live up to our expectations?
Elinor McCartney, President for Pen & Tec Consulting
10:30 - 11:00

Morning Coffee & Networking Break

Day 1 | 11:00 - 11:30
Dissecting the human skin microbiome in health and disease
Huiying Li, Associate Professor at University of California, Los Angeles
Day 2 | 11:00 - 11:30
The probiotic potential of SYMPROVE: an in-depth study using the SHIME® technology platform
Frédéric Moens, Head of Research And Development at ProDigest
Day 1 | 11:30 - 12:00
Is human skin microbiota a goldmine for personalized diagnostic tests?
Alexandre Passioukov, Vice President Translational Medicine at Pierre Fabre
Day 2 | 11:30 - 12:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 1 | 12:00 - 12:30
Integrated gut biology
David Berry, General Partner at Flagship Pioneering
Day 2 | 12:00 - 13:00
Panel Discussion
Pre and Probiotics: A Shift from Pharmaceuticals to Nutraceuticals
Day 1 | 12:30 - 13:00
Platform that allows to study the connections among diet, gut microbiome, immune system, human physiology, and health/disease states
Momo Vuyisich, Founder and Chief Science Officer at Viome
13:00 - 14:00

Lunch Break

Day 1 | 14:00 - 14:30
Translating the Human Gut Microbiome- Progress through Innovation and Investment
Denise Kelly, Investment Advisor at Seventure
Day 2 | 14:00 - 14:30
TOP-5 Poster Presentations (5min. On Stage)
Click here to submit your poster
Day 1 | 14:30 - 15:00
Speaking Sponsorship Available - Have your talk here
Click here to register
Day 2 | 14:30 - 15:00
Speaking Sponsorship Available - Have your talk here
Click here to register
15:00 - 15:30

Afternoon Coffee & Networking Break

Day 1 | 15:30 - 16:00
Ketogenic diet and the gut microbiota
Fabio Piccini Co-founder and Director at Progetto Microbioma Italiano
Day 2 | 15:30 - 16:00
Quality control of probiotics and internationalisation of the ESLP initiative
Jean-Pol Warzée, President at European Scientific League for Probiotics – ESLP
Day 1 | 16:00 - 16:30
Studying the variability of intestinal microbiome in mice to better understand the Human microbiome
Pavlovic Guillaume Head of Unit at PHENOMIN-ICS
Day 2 | 16:00 - 16:30
Topic to be announced
Adam Baker, Director of Science at Chr. Hansen Holding A/S
Day 1 | 16:30 - 17:00
An abnormal microbiome in Anorexia Nervosa – implications for interventions
Magnus Sjögren, PhD Associate Professor at University of Gothenburg
Day 1 | 16:30 - 17:00
Pre-clinical selection of probiotics strains: Six simple steps
Peter Cartwright Human Microecology Specialist
Day 1 | 17:00 - 17:30
Panel Discussion
The Development Of New Therapies In Skin Microbiome
Day 2 | 17:00
Chairman's closing remarks & End of the Probiotics, Human & Skin Microbiome event

DAY 1 | 20:00 - 22:30

Monday night business dinner

The BioTech Pharma Summit 2021: Gala Dinner

Sponsor this event - Click here
IRDD_Gala_Dinner_New_York_Inhalation_Drug_Delivery

Aseptic Processing Technology Agenda

Agenda is being produced and will be announced soon.
Click here to speak at this event
Click here to find the Confirmed speakers
C0066.00_09_22_27.Still064

CDx/Biomarkers & Biobanking Agenda

Agenda is being produced and will be announced soon.
Click here to speak at this event
Click here to find the Confirmed speakers
C0019.00_03_18_08.Still092

Slide BIOTECH PHARMA SUMMIT - PORTO / 2021 REGISTER NOW